IVIG vs SCIG in CIDP

Clinical trial NCT05584631 · RECRUITING

Trial details

NCT number: NCT05584631
Sponsor: Rutgers, The State University of New Jersey
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CIDP Immunoglobulin Deficiency Chronic Inflammatory Demyelinating Polyneuropathy

Start date: 2022-09-11
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.